Clin2
NCT06264492Likely a fitNot yet recruiting

Participation trends in scleroderma studies

Scleroderma

Part of Skin clinical trials.

This study looks at what makes people with scleroderma decide to join clinical trials. By participating, you help doctors understand how to make trials easier and more accessible for patients like you.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with scleroderma.
  • You are 18 years old or older.
  • You are planning to join an observational clinical trial.
  • You are not pregnant.
  • You can complete online surveys or reports regularly.
  • You can understand and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01656447Recruiting
Scleroderma patient registry and tissue repository study

This study builds a registry of people with scleroderma and may store medical information and samples for future research. It can help researchers better understand the disease and develop better treatments.

New York, New York
NCT04265144Recruiting
Study group of adults with scleroderma for ongoing care research

This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.

Bordeaux
NCT07256418Recruiting
Skin cell study for scleroderma

This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.

Dijon
NCT07183072Recruiting
Scleroderma: Physical Performance and Functionality Study

This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.

Çankaya, Ankara
NCT06195072Recruiting· Phase 2
Platform study for scleroderma with lung disease

This trial tests new treatments for people with scleroderma-related lung disease. You may be eligible if you have systemic sclerosis with lung scarring, your symptoms started within the last 7 years, and you have not had certain prior treatments or transplants.

Birmingham, Alabama
NCT06338358Not yet recruiting
Understanding participation habits among plaque psoriasis patients

This study looks at why people with plaque psoriasis do or don't take part in clinical trials. It aims to learn more about participation habits to make future trials easier to join.

San Francisco, California

Hear when a new Scleroderma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.